Cited by 30Ovarian function and disordersAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Investigation of common risk factors between polycystic ovary syndrome and Alzheimer’s disease: a narrative review

Open access
Sarahian, Nahid, Sarvazad, Hosna, Sajadi, Elham, Rahnejat, Nasrin, Eskandari Roozbahani, Narges·2021·Reproductive Health

Published version of a preprint

Abstract

Background: The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance are also the main factors influencing the clinical manifestations of this syndrome. Alzheimer’s disease (AD) is the most typical progressive neurodegenerative disorder of the brain, and recent studies suggest a relationship between endocrinal dysregulation and neuronal loss during AD pathology. Aim: This study aimed to evaluate the common risk factors for Alzheimer’s and PCOS based on previous studies. Knowing the common risk factors and eliminating them may prevent neurodegenerative Alzheimer’s disease in the future. Method: In this narrative review, international databases, including Google Scholar, Scopus, PubMed, and the Web of Science, were searched to retrieve the relevant studies. The relevant studies’ summaries were categorized to discuss the possible pathways that may explain the association between Alzheimer’s and PCOS signs/symptoms and complications. Results: According to our research, the factors involved in Alzheimer’s and PCOS disorders may share some common risk factors. In patients with PCOS, increased LH to FSH ratio, decreased vitamin D, insulin resistance, and obesity are some of the most important factors that may increase the risk of Alzheimer’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12978-021-01203-x

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study used separate coding for hypertension, myocardial infarction, and CVD, whereas other epidemiologic studies often combine these within one definition of CVD.

    “For example, we used separate coding for hypertension, myocardial infarction, and CVD, whereas in other epidemiologic studies, these are often combined within one definition of CVD.18,51, 52, 53,139”

    From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [139]

    The citing authors’ separate coding is their own method, not a finding attributed to this source. The cited review’s Methods describe a literature search, and its Results discuss metabolic and cardiovascular risk factors, but no passage addresses whether epidemiologic studies combine hypertension, myocardial infarction, and CVD into one definition. Searches for those conditions and for CVD coding found no relevant passage; page numbers were unavailable. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • The study used validated ICD coding for diseases using the Charlson Comorbidity Index and specific ICD codes for disease.

    “We used validated ICD coding for diseases using the Charlson Comorbidity Index and specific ICD codes for disease.”

    From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [139]

    The Methods section describes a literature search and selection of studies for a narrative review. Our copy does not address validated ICD coding, the Charlson Comorbidity Index, or disease-specific ICD codes; searches for those terms found no relevant passage. The citing sentence describes the citing authors’ own methods, which this source cannot verify. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 122 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [80]Spinedi E Cardinali DP The polycystic ovary syndrome and the metabolic syndrome: a possible chronobiotic-cytoprotective adjuvant therapy Int J Endocrinol 2018 2018 1349868 10.1155/2018/1349868 30147722 PMC6083563 · DOI
  2. [98]Landel V Annweiler C Millet P Morello M Féron F Vitamin D Cognition and Alzheimer's disease: the therapeutic benefit is in the D-tails J Alzheimer's Dis JAD 2016 53 2 419 444 10.3233/JAD-150943 27176073 PMC4969697 · DOI

Cited by

Sorted by citations

Authors
Sarahian, N., Sarvazad, H., Sajadi, E., Rahnejat, N., & Eskandari Roozbahani, N.
Affiliations
  • Shahid Beheshti University (IR)
  • Kermanshah University of Medical Sciences (IR)
  • Shiraz University (IR)
Venue
Reproductive Health
Published
2021-07-26
Volume
18
Issue
1
Pages
156-156
ISSN
1742-4755 (ISSN-L)
OpenAlex
W3186422250
Cited by
30
References
122
Citations by year
2026: 8 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 3
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • Reproductive Health (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
polycystic ovary syndrome, Alzheimer's disease, shared risk factors, insulin resistance, obesity, hyperandrogenism, vitamin D deficiency, neurodegeneration, endocrine dysfunction
MeSH terms
Alzheimer Disease, Anovulation, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Risk Factors, Hyperandrogenism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review